Sudden cardiac death after myocardial infarction in patients with type 2 diabetes.

[1]  T. Rea,et al.  Type 2 diabetes mellitus and the risk of sudden cardiac arrest in the community , 2010, Reviews in Endocrine and Metabolic Disorders.

[2]  J. Pankow,et al.  Diabetes and the risk of sudden cardiac death, the Atherosclerosis Risk in Communities study , 2010, Acta Diabetologica.

[3]  A. Castellanos,et al.  Indications for implantable cardioverter-defibrillators based on evidence and judgment. , 2009, Journal of the American College of Cardiology.

[4]  Dawn Peters,et al.  Determinants of Prolonged QT Interval and Their Contribution to Sudden Death Risk in Coronary Artery Disease: The Oregon Sudden Unexpected Death Study , 2009, Circulation.

[5]  M. Malik,et al.  Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk) , 2008, European heart journal.

[6]  Robert J. Myerburg,et al.  Implantable cardioverter-defibrillators after myocardial infarction. , 2008, The New England journal of medicine.

[7]  Karl Swedberg,et al.  Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. , 2008, European heart journal.

[8]  A. Moss,et al.  Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. , 2008, Journal of the American College of Cardiology.

[9]  Robert S Sheldon,et al.  Noninvasive risk assessment early after a myocardial infarction the REFINE study. , 2007, Journal of the American College of Cardiology.

[10]  S. Solomon,et al.  Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. , 2005, The New England journal of medicine.

[11]  H. Huikuri,et al.  Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era. , 2005, European heart journal.

[12]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[13]  Gareth Ambler,et al.  Cardiovascular risk and diabetes. Are the methods of risk prediction satisfactory? , 2004, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[14]  A. Moss,et al.  Time Dependence of Mortality Risk and Defibrillator Benefit After Myocardial Infarction , 2004, Circulation.

[15]  Pekka Raatikainen,et al.  Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. , 2003, Journal of the American College of Cardiology.

[16]  Jixian Wang,et al.  Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies , 2002, BMJ : British Medical Journal.

[17]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[18]  H. Huikuri,et al.  Sudden death due to cardiac arrhythmias. , 2001, The New England journal of medicine.

[19]  H. Keen,et al.  Mortality and causes of death in the WHO multinational study of vascular disease in diabetes , 2001, Diabetologia.

[20]  H. Huikuri,et al.  Prognostic Significance of Risk Stratifiers of Mortality, Including T Wave Alternans, After Acute Myocardial Infarction: Results of a Prospective Follow‐Up Study , 2001, Journal of cardiovascular electrophysiology.

[21]  P. Zimmet.  Globalization, coca‐colonization and the chronic disease epidemic: can the Doomsday scenario be averted? , 2000, Journal of internal medicine.

[22]  P. Passa,et al.  [Cardiovascular risk and diabetes]. , 1998, Annales d'endocrinologie.

[23]  M. Laakso,et al.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. , 1998, The New England journal of medicine.

[24]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[25]  R. Myerburg,et al.  Sudden Cardiac Death: Epidemiology, Transient Risk, and Intervention Assessment , 1993, Annals of Internal Medicine.

[26]  J. Neaton,et al.  Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.

[27]  R. Myerburg,et al.  Arrhythmogenic Effects of Graded Coronary Blood Flow Reductions Superimposed on Prior Myocardial Infarction in Dogs , 1991, Circulation.

[28]  D L McGee,et al.  Diabetes and Cardiovascular Risk Factors: The Framingham Study , 1979, Circulation.